INVENTIVA (EPA:IVA) Inventiva and Hepalys Pharma, Inc. announce exclusive licensing agreement to develop and commercialize lanifibranor in Japan and South Korea
Transparency directive : regulatory news
20/09/2023 22:00
INVENTIVA 's latest news
03/04/2024 22:00
27/03/2024 21:00
22/03/2024 21:00
18/03/2024 21:00
13/03/2024 21:00
07/03/2024 22:00
24/01/2024 22:15
10/01/2024 22:00
20/12/2023 22:00
04/12/2023 22:05
Other stories
17/05/2024 03:30
17/05/2024 03:15
17/05/2024 06:59
16/05/2024 23:01
16/05/2024 15:10
17/05/2024 02:47
16/05/2024 22:32
16/05/2024 19:04
17/05/2024 04:53
16/05/2024 20:32
17/05/2024 05:41
16/05/2024 18:22
16/05/2024 19:04
17/05/2024 05:45
16/05/2024 23:20
17/05/2024 00:22
16/05/2024 18:28
16/05/2024 20:25
Former Post Office executive tells Horizon inquiry she blocked Paula Vennells’ number - The Guardian
16/05/2024 17:10
16/05/2024 00:05
16/05/2024 15:39
15/05/2024 16:03
16/05/2024 18:00
17/05/2024 03:31
16/05/2024 14:00
17/05/2024 06:38
16/05/2024 23:23
17/05/2024 00:30
16/05/2024 22:54
17/05/2024 03:00
15/05/2024 11:44
16/05/2024 09:24
15/05/2024 17:00
16/05/2024 21:46
16/05/2024 13:00
16/05/2024 17:46
16/05/2024 10:15
16/05/2024 10:02